Judge Denied Class Certification for BlueCross Lawsuit
The ruling prevents 74 cancer patients from suing as a group over denied proton therapy coverage.
Updated on Sept. 29, 2026 in Healthcare
Live Poll
Do you trust that insurance companies sufficiently cover essential cancer treatments?
A federal judge declined to certify a class action lawsuit against BlueCross BlueShield of Tennessee regarding the insurer's refusal to cover proton beam radiation therapy. The proposed class consisted of 74 cancer patients seeking coverage for their treatments.
Why it matters
The court found that individual analysis of treatment costs and associated damages is necessary for each patient, meaning common questions of law do not predominate. This ruling effectively shifts the legal strategy for these claimants from a collective action to individual suits.
The proposed class included 74 patients. The judge ruled that the group failed to meet legal requirements because damages must be calculated based on individual treatment costs rather than a uniform standard.
The players
BlueCross BlueShield of Tennessee
A health insurance provider that manages coverage policies for policyholders across Tennessee.
Travis R. McDonough
A federal judge who issued the ruling regarding class action certification.
The details
Judge Travis R. McDonough determined that each insurance denial requires a unique look at a patient's specific medical history and associated costs. By denying class certification, the court signaled that the procedural benefits of a class action do not outweigh the need for granular review of each case. Claimants must now demonstrate their individual eligibility and loss rather than relying on a shared legal argument.
Timeline
September 28, 2026: Judge Travis R. McDonough declined to certify the class.
Market Landscape
This decision follows the established legal precedent of the Rule 23 predominance requirement, which governs whether a group has enough in common to sue collectively. It limits the ability of claimants to aggregate medical insurance disputes that require case-by-case damage assessments.
Operators managing insurance-related disputes should note that individual cost calculations can act as a significant barrier to class certification. Businesses should maintain detailed documentation of individual service delivery and claim denials to support defense in specific, rather than class-wide, litigation.
The takeaway
The court's decision highlights that insurance coverage disputes are difficult to scale into class actions when damages vary widely by patient. Legal and compliance teams should monitor how individual damage calculations influence the viability of future litigation against their benefit plans.
Further reading
For broader trends in medical insurance policy and litigation, visit the Healthcare section.
Live Poll
Do you trust that insurance companies sufficiently cover essential cancer treatments?
